textbook: 
"Principles and Practice of Drug Development: A Comprehensive Guide":

chapters:
- Chapter 1: Introduction From Discovery to Market: An Integrated View:
sections:
- Section: 1.1 Back to the Lab:
subsections:
- 1.1a Drug Discovery Process
- 1.1b Preclinical Testing
- 1.1c Clinical Trials

- Section: 1.2 Lessons from 60 Years of Pharmaceutical Innovation:
subsections:
- 1.2a Evolution of Drug Development
- 1.2b Major Breakthroughs and Challenges
- 1.2c Future Trends

- Section: 1.3 FY 2011 Innovative Drug Approvals:
subsections:
- 1.3a Overview of Approved Drugs
- 1.3b Impact on Healthcare
- 1.3c Regulatory Aspects

- Chapter 2: Brief Economic History of the Pharmaceutical Industry:
sections:
- Section: 2.1 Evolving Economics:
subsections:
- 2.1a Economic Factors Influencing Drug Development
- 2.1b Cost of Drug Development
- 2.1c Market Dynamics

- Section: 2.2 Emergence of Biopharmaceuticals:
subsections:
- 2.2a Definition and Characteristics
- 2.2b Impact on Drug Development
- 2.2c Future Prospects

- Section: 2.3 Impact of Globalization on Drug Development:
subsections:
- 2.3a Globalization and its Impact
- 2.3b Challenges and Opportunities
- 2.3c Case Studies

- Chapter 3: The Pharmaceutical Industry and the Drug Development Process; Basic Science:
sections:
- Section: 3.1 History of Pharmaceuticals:
subsections:
- 3.1a Early History
- 3.1b Modern Pharmaceutical Industry
- 3.1c Future Trends

- Section: 3.2 Pharmaceutical Research and Development (R&D):
subsections:
- 3.2a R&D Process
- 3.2b Role of R&D in Drug Development
- 3.2c Challenges and Opportunities

- Section: 3.3 Drug Discovery and Target Identification:
subsections:
- 3.3a Drug Discovery Process
- 3.3b Target Identification Techniques
- 3.3c Case Studies

- Section: 3.4 Preclinical Development:
subsections:
- 3.4a Preclinical Testing
- 3.4b Regulatory Aspects
- 3.4c Case Studies

- Chapter 4: Business of Biopharmaceuticals:
sections:
- Section: 4.1 Comparative Effectiveness:
subsections:
- 4.1a Definition and Importance
- 4.1b Comparative Effectiveness Research
- 4.1c Case Studies

- Section: 4.2 Drug Regulation:
subsections:
- 4.2a Regulatory Bodies
- 4.2b Drug Approval Process
- 4.2c Regulatory Challenges

- Section: 4.3 Intellectual Property Rights and Patents:
subsections:
- 4.3a Importance of IP Rights
- 4.3b Patent Process
- 4.3c Case Studies

- Section: 4.4 Biopharmaceutical Licensing and Partnerships:
subsections:
- 4.4a Importance of Licensing and Partnerships
- 4.4b Process and Challenges
- 4.4c Case Studies

- Section: 4.5 Marketing and Commercialization Strategies:
subsections:
- 4.5a Marketing Strategies in Pharma
- 4.5b Commercialization Process
- 4.5c Case Studies

- Chapter 5: Accelerating Cancer Cures: A Global Frontier:
sections:
- Section: 5.1 Guest Lecturer: Robert Mulroy, M. P. P. M., Director, President & CEO, Merrimack Pharmaceuticals:
subsections:
- 5.1a Introduction to Merrimack Pharmaceuticals
- 5.1b Role in Cancer Drug Development
- 5.1c Future Prospects

- Section: 5.2 Guest Lecturer: Sumit Khedekar, Dir:
subsections:
- 5.2a Introduction to Sumit Khedekar
- 5.2b Role in Drug Development
- 5.2c Future Prospects

- Chapter 6: Clinical Drug Development:
sections:
- Section: 6.1 Comparative Effectiveness:
subsections:
- 6.1a Definition and Importance
- 6.1b Comparative Effectiveness Research
- 6.1c Case Studies

- Section: 6.2 Drug Regulation:
subsections:
- 6.2a Regulatory Bodies
- 6.2b Drug Approval Process
- 6.2c Regulatory Challenges

- Section: 6.3 Clinical Trial Design and Phases:
subsections:
- 6.3a Clinical Trial Design
- 6.3b Phases of Clinical Trials
- 6.3c Case Studies

- Section: 6.4 Ethics in Clinical Trials:
subsections:
- 6.4a Importance of Ethics
- 6.4b Ethical Challenges
- 6.4c Case Studies

- Section: 6.5 Data Collection and Analysis:
subsections:
- 6.5a Data Collection Methods
- 6.5b Data Analysis Techniques
- 6.5c Case Studies

- Section: 6.6 Safety Monitoring and Reporting:
subsections:
- 6.6a Importance of Safety Monitoring
- 6.6b Reporting Adverse Events
- 6.6c Case Studies

- Chapter 7: Drug Delivery Systems:
sections:
- Section: 7.1 Manufacturing:
subsections:
- 7.1a Drug Manufacturing Process
- 7.1b Quality Control
- 7.1c Case Studies

- Section: 7.2 Oral Drug Delivery Systems:
subsections:
- 7.2a Types of Oral Drug Delivery Systems
- 7.2b Advantages and Disadvantages
- 7.2c Case Studies

- Section: 7.3 Injectable Drug Delivery Systems:
subsections:
- 7.3a Types of Injectable Drug Delivery Systems
- 7.3b Advantages and Disadvantages
- 7.3c Case Studies

- Section: 7.4 Transdermal Drug Delivery Systems:
subsections:
- 7.4a Types of Transdermal Drug Delivery Systems
- 7.4b Advantages and Disadvantages
- 7.4c Case Studies

- Section: 7.5 Inhalation Drug Delivery Systems:
subsections:
- 7.5a Types of Inhalation Drug Delivery Systems
- 7.5b Advantages and Disadvantages
- 7.5c Case Studies

- Section: 7.6 Implantable Drug Delivery Systems:
subsections:
- 7.6a Types of Implantable Drug Delivery Systems
- 7.6b Advantages and Disadvantages
- 7.6c Case Studies

- Section: 7.7 Nanotechnology in Drug Delivery:
subsections:
- 7.7a Introduction to Nanotechnology
- 7.7b Role in Drug Delivery
- 7.7c Case Studies

- Chapter 8: Regulation:
sections:
- Section: 8.1 Comparative Effectiveness:
subsections:
- 8.1a Definition and Importance
- 8.1b Comparative Effectiveness Research
- 8.1c Case Studies

- Section: 8.2 Drug Regulation:
subsections:
- 8.2a Regulatory Bodies
- 8.2b Drug Approval Process
- 8.2c Regulatory Challenges

- Section: 8.3 FDA Drug Approval Process:
subsections:
- 8.3a FDA Approval Process
- 8.3b Challenges and Controversies
- 8.3c Case Studies

- Section: 8.4 EMA Drug Approval Process:
subsections:
- 8.4a EMA Approval Process
- 8.4b Challenges and Controversies
- 8.4c Case Studies

- Section: 8.5 Regulatory Affairs and Compliance:
subsections:
- 8.5a Role of Regulatory Affairs
- 8.5b Compliance in Pharma
- 8.5c Case Studies

- Section: 8.6 Pharmacovigilance and Post-Marketing Surveillance:
subsections:
- 8.6a Importance of Pharmacovigilance
- 8.6b Post-Marketing Surveillance
- 8.6c Case Studies

- Chapter 9: Manufacturing III:
sections:
- Section: 9.1 Manufacturing:
subsections:
- 9.1a Drug Manufacturing Process
- 9.1b Quality Control
- 9.1c Case Studies

- Section: 9.2 Good Manufacturing Practices (GMP):
subsections:
- 9.2a Introduction to GMP
- 9.2b Role in Quality Control
- 9.2c Case Studies

- Section: 9.3 Quality Control and Assurance:
subsections:
- 9.3a Importance of Quality Control
- 9.3b Quality Assurance in Pharma
- 9.3c Case Studies

- Section: 9.4 Production Scale-Up and Technology Transfer:
subsections:
- 9.4a Scale-Up Process
- 9.4b Technology Transfer in Pharma
- 9.4c Case Studies

- Section: 9.5 Supply Chain Management:
subsections:
- 9.5a Importance of Supply Chain Management
- 9.5b Challenges in Pharma Supply Chain
- 9.5c Case Studies

- Section: 9.6 Outsourcing Strategies:
subsections:
- 9.6a Role of Outsourcing in Pharma
- 9.6b Advantages and Disadvantages
- 9.6c Case Studies

- Chapter 10: Drug Discovery and Development:
sections:
- Section: 10.1 Drug Discovery Process:
subsections:
- 10.1a Steps in Drug Discovery
- 10.1b Role of Bioinformatics
- 10.1c Case Studies

- Section: 10.2 Preclinical Development:
subsections:
- 10.2a Preclinical Testing
- 10.2b Regulatory Aspects
- 10.2c Case Studies

- Section: 10.3 Clinical Trials:
subsections:
- 10.3a Phases of Clinical Trials
- 10.3b Ethical Considerations
- 10.3c Case Studies

- Section: 10.4 Drug Approval and Post-Marketing Surveillance:
subsections:
- 10.4a Drug Approval Process
- 10.4b Post-Marketing Surveillance
- 10.4c Case Studies

- Chapter 11: Biopharmaceuticals:
sections:
- Section: 11.1 Introduction to Biopharmaceuticals:
subsections:
- 11.1a Definition and Characteristics
- 11.1b Role in Modern Medicine
- 11.1c Case Studies

- Section: 11.2 Development of Biopharmaceuticals:
subsections:
- 11.2a Biopharmaceutical R&D
- 11.2b Preclinical and Clinical Development
- 11.2c Case Studies

- Section: 11.3 Regulation of Biopharmaceuticals:
subsections:
- 11.3a Regulatory Bodies
- 11.3b Approval Process
- 11.3c Case Studies

- Section: 11.4 Manufacturing and Quality Control of Biopharmaceuticals:
subsections:
- 11.4a Manufacturing Process
- 11.4b Quality Control
- 11.4c Case Studies

- Chapter 12: Pharmacoeconomics:
sections:
- Section: 12.1 Introduction to Pharmacoeconomics:
subsections:
- 12.1a Definition and Importance
- 12.1b Role in Drug Development
- 12.1c Case Studies

- Section: 12.2 Cost-Effectiveness Analysis:
subsections:
- 12.2a Definition and Importance
- 12.2b Role in Decision Making
- 12.2c Case Studies

- Section: 12.3 Budget Impact Analysis:
subsections:
- 12.3a Definition and Importance
- 12.3b Role in Decision Making
- 12.3c Case Studies

- Section: 12.4 Pharmacoeconomic Modeling:
subsections:
- 12.4a Introduction to Pharmacoeconomic Modeling
- 12.4b Role in Decision Making
- 12.4c Case Studies

- Chapter 13: Drug Safety and Pharmacovigilance:
sections:
- Section: 13.1 Introduction to Drug Safety:
subsections:
- 13.1a Definition and Importance
- 13.1b Role in Drug Development
- 13.1c Case Studies

- Section: 13.2 Pharmacovigilance:
subsections:
- 13.2a Definition and Importance
- 13.2b Role in Drug Safety
- 13.2c Case Studies

- Section: 13.3 Adverse Drug Reactions:
subsections:
- 13.3a Definition and Types
- 13.3b Role in Drug Safety
- 13.3c Case Studies

- Section: 13.4 Risk Management in Drug Safety:
subsections:
- 13.4a Introduction to Risk Management
- 13.4b Role in Drug Safety
- 13.4c Case Studies

- Chapter 14: Drug Marketing and Commercialization:
sections:
- Section: 14.1 Introduction to Drug Marketing:
subsections:
- 14.1a Definition and Importance
- 14.1b Role in Drug Development
- 14.1c Case Studies

- Section: 14.2 Drug Commercialization:
subsections:
- 14.2a Definition and Importance
- 14.2b Role in Drug Development
- 14.2c Case Studies

- Section: 14.3 Marketing Strategies in Pharma:
subsections:
- 14.3a Different Marketing Strategies
- 14.3b Role in Drug Commercialization
- 14.3c Case Studies

- Section: 14.4 Market Access and Pricing:
subsections:
- 14.4a Introduction to Market Access
- 14.4b Role in Drug Commercialization
- 14.4c Case Studies

- Chapter 15: Regulatory Affairs in Pharma:
sections:
- Section: 15.1 Introduction to Regulatory Affairs:
subsections:
- 15.1a Definition and Importance
- 15.1b Role in Drug Development
- 15.1c Case Studies

- Section: 15.2 Drug Regulation:
subsections:
- 15.2a Regulatory Bodies
- 15.2b Drug Approval Process
- 15.2c Case Studies

- Section: 15.3 Compliance in Pharma:
subsections:
- 15.3a Definition and Importance
- 15.3b Role in Regulatory Affairs
- 15.3c Case Studies

- Section: 15.4 Post-Marketing Surveillance:
subsections:
- 15.4a Definition and Importance
- 15.4b Role in Regulatory Affairs
- 15.4c Case Studies

- Chapter 16: Quality Control and Assurance in Pharma:
sections:
- Section: 16.1 Introduction to Quality Control:
subsections:
- 16.1a Definition and Importance
- 16.1b Role in Drug Development
- 16.1c Case Studies

- Section: 16.2 Quality Assurance:
subsections:
- 16.2a Definition and Importance
- 16.2b Role in Quality Control
- 16.2c Case Studies

- Section: 16.3 Good Manufacturing Practices (GMP):
subsections:
- 16.3a Introduction to GMP
- 16.3b Role in Quality Control
- 16.3c Case Studies

- Section: 16.4 Quality Management Systems:
subsections:
- 16.4a Introduction to Quality Management Systems
- 16.4b Role in Quality Control
- 16.4c Case Studies

- Chapter 17: Drug Manufacturing:
sections:
- Section: 17.1 Drug Manufacturing Process:
subsections:
- 17.1a Steps in Drug Manufacturing
- 17.1b Role of Quality Control
- 17.1c Case Studies

- Section: 17.2 Production Scale-Up:
subsections:
- 17.2a Definition and Importance
- 17.2b Role in Drug Manufacturing
- 17.2c Case Studies

- Section: 17.3 Technology Transfer in Pharma:
subsections:
- 17.3a Definition and Importance
- 17.3b Role in Drug Manufacturing
- 17.3c Case Studies

- Section: 17.4 Outsourcing in Pharma Manufacturing:
subsections:
- 17.4a Definition and Importance
- 17.4b Role in Drug Manufacturing
- 17.4c Case Studies

- Chapter 18: Supply Chain Management in Pharma:
sections:
- Section: 18.1 Introduction to Supply Chain Management:
subsections:
- 18.1a Definition and Importance
- 18.1b Role in Drug Development
- 18.1c Case Studies

- Section: 18.2 Logistics in Pharma:
subsections:
- 18.2a Definition and Importance
- 18.2b Role in Supply Chain Management
- 18.2c Case Studies

- Section: 18.3 Inventory Management in Pharma:
subsections:
- 18.3a Definition and Importance
- 18.3b Role in Supply Chain Management
- 18.3c Case Studies

- Section: 18.4 Distribution in Pharma:
subsections:
- 18.4a Definition and Importance
- 18.4b Role in Supply Chain Management
- 18.4c Case Studies

- Chapter 19: Pharmacovigilance and Drug Safety:
sections:
- Section: 19.1 Introduction to Pharmacovigilance:
subsections:
- 19.1a Definition and Importance
- 19.1b Role in Drug Safety
- 19.1c Case Studies

- Section: 19.2 Adverse Drug Reactions:
subsections:
- 19.2a Definition and Types
- 19.2b Role in Pharmacovigilance
- 19.2c Case Studies

- Section: 19.3 Risk Management in Drug Safety:
subsections:
- 19.3a Introduction to Risk Management
- 19.3b Role in Pharmacovigilance
- 19.3c Case Studies

- Section: 19.4 Post-Marketing Surveillance:
subsections:
- 19.4a Definition and Importance
- 19.4b Role in Pharmacovigilance
- 19.4c Case Studies

- Chapter 20: Future Trends in Drug Development:
sections:
- Section: 20.1 Personalized Medicine:
subsections:
- 20.1a Definition and Importance
- 20.1b Role in Future Drug Development
- 20.1c Case Studies

- Section: 20.2 Biopharmaceuticals:
subsections:
- 20.2a Future Trends in Biopharmaceuticals
- 20.2b Role in Future Drug Development
- 20.2c Case Studies

- Section: 20.3 Nanotechnology in Drug Development:
subsections:
- 20.3a Future Trends in Nanotechnology
- 20.3b Role in Future Drug Development
- 20.3c Case Studies

- Section: 20.4 Digital Health and Drug Development:
subsections:
- 20.4a Future Trends in Digital Health
- 20.4b Role in Future Drug Development
- 20.4c Case Studies